Advertisement
Financing › Details
Chr. Hansen–Novozymes: investment, 202212– merger acquisition valuing Chr Hansen at DKK660.55/share ANNOUNCED
Period | 2022-12-12 | |
Money taker | Chr. Hansen Holding A/S | |
Group | Chr. Hansen (Group) | |
Money source | Novozymes A/S | |
Group | Novozymes (Group) | |
Product | industrial biotechnology | |
Product 2 | food ingredient | |
Person | Kutay, Kasim (Novo Group 201706 CEO of Novo Holdings A/S) | |
Source | Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. | |
Record changed: 2022-12-12 |
Advertisement
More documents for Chr. Hansen (Group)
- [1] Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen....
- [2] Chr. Hansen Holding A/S. (9/22/20). "Press Release: Chr. Hansen Acquires Jennewein Biotechnologie GmbH to Enter and Lead the High-growth Human Milk Oligosaccharides Market"....
- [3] Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel....
- [4] Tecan Group Ltd.. (6/2/17). "Press Release: Tecan Appoints Erik Norström Head of Corporate Development". Männedorf....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top